Growth hormone replacement therapy reduces risk of cancer in adult with growth hormone deficiency: A meta-analysis (Q37697234)

22 August 2017

3 references

20 November 2019

17 December 2020

21 April 2021

0 references

Growth hormone replacement therapy reduces risk of cancer in adult with growth hormone deficiency: A meta-analysis (English)

1 reference

hormone replacement therapy

22 August 2017

1 reference

20 November 2019

1 reference

20 November 2019

3 references

20 November 2019

17 December 2020

21 April 2021

3 references

20 November 2019

17 December 2020

21 April 2021

1 reference

19 September 2019

1 reference

17 November 2019

2 references

21 April 2021

Hormone Replacement Therapy

1 reference

growth hormone deficiency

inferred from title

1 reference

1 reference

Zhanzhan Li

1

1 reference

22 August 2017

Qin Zhou

2

1 reference

22 August 2017

Yanyan Li

3

1 reference

22 August 2017

Jun Fu

4

1 reference

22 August 2017

Xinqiong Huang

5

1 reference

22 August 2017

Liangfang Shen

6

1 reference

22 August 2017

language of work or name

English

0 references

publication date

9 November 2016

1 reference

22 August 2017

6 December 2016

10 references

13 March 2019

24 March 2019

3 April 2019

25 April 2019

25 June 2019

19 September 2019

17 November 2019

20 November 2019

17 December 2020

21 April 2021

11 references

22 August 2017

13 March 2019

24 March 2019

3 April 2019

25 April 2019

25 June 2019

19 September 2019

17 November 2019

20 November 2019

17 December 2020

21 April 2021

7

1 reference

22 August 2017

81862-81869

1 reference

22 August 2017

49

1 reference

Creative Commons Attribution 3.0 Unported

22 August 2017

10 references

13 March 2019

24 March 2019

3 April 2019

25 April 2019

25 June 2019

19 September 2019

17 November 2019

20 November 2019

17 December 2020

on focus list of Wikimedia project

21 April 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Effect of Growth Hormone Treatment on Fractures and Quality of Life in Postmenopausal Osteoporosis: A 10-Year Follow-Up Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Does growth hormone cause cancer?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Measuring inconsistency in meta-analyses

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

The somatomedin hypothesis: 2001.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Bias in meta-analysis detected by a simple, graphical test

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Operating characteristics of a rank correlation test for publication bias

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Meta-analysis in clinical trials

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Cardiovascular Risk in Growth Hormone Deficiency: Beneficial Effects of Growth Hormone Replacement Therapy.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Growth hormone deficiency: an update.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Growth hormone, the insulin-like growth factor axis, insulin and cancer risk.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Ten-year change in quality of life in adults on growth hormone replacement for growth hormone deficiency: an analysis of the hypopituitary control and complications study.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Effect of long-term GH replacement therapy on cardiovascular outcomes in GH-deficient patients previously treated for acromegaly: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Long-term safety of growth hormone replacement after CNS irradiation.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5348436

Influence of GH substitution therapy in deficient adults on the recurrence rate of hormonally inactive pituitary adenomas: a case control study

1 September 2018

1 reference

12 December 2020

More about: prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3

1 reference

12 December 2020

Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy

1 reference

12 December 2020

Adult growth hormone deficiency

1 reference

12 December 2020

Insulin-like growth factors and neoplasia

1 reference

12 December 2020

10.18632/ONCOTARGET.13251

Identifiers

DOI

1 reference

22 August 2017

1 reference

22 August 2017

1 reference